Gene encoding labyrinthin, a marker for cancer

Details for Australian Patent Application No. 2008202039 (hide)

Owner ImmvaRx, Inc.

Inventors Radosevich, James A.

Agent Spruson & Ferguson

Pub. Number AU-A-2008202039

Parent 2003204331

Filing date 7 May 2008

Wipo publication date 29 May 2008

International Classifications

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

22 May 2008 Complete Application Filed

29 May 2008 Application Open to Public Inspection

  Published as AU-A-2008202039

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202040-Improved boat hull

2008202038-System and method for controlling a vehicle with a sequence of vehicle events